These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9885204)

  • 21. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
    Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
    Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy of sepsis.
    van der Poll T
    Lancet Infect Dis; 2001 Oct; 1(3):165-74. PubMed ID: 11871493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in the development of an acute neutrophil inflammatory response in mice.
    Metcalf D; Robb L; Dunn AR; Mifsud S; Di Rago L
    Blood; 1996 Nov; 88(10):3755-64. PubMed ID: 8916939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediators of systemic inflammatory response syndrome and the role of recombinant activated protein C in sepsis syndrome.
    Kak V
    Infect Dis Clin North Am; 2011 Dec; 25(4):835-50. PubMed ID: 22054759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to leverage an endogenous immune defense mechanism: the example of granulocyte colony-stimulating factor.
    Hartung T; Von Aulock S; Schneider C; Faist E
    Crit Care Med; 2003 Jan; 31(1 Suppl):S65-75. PubMed ID: 12544979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects and mechanisms of insulin on systemic inflammatory response and immune cells in severe trauma, burn injury, and sepsis.
    Deng HP; Chai JK
    Int Immunopharmacol; 2009 Oct; 9(11):1251-9. PubMed ID: 19647101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current status and prospect of integrative immune-therapy on pyaemia].
    Xiong XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Aug; 30(8):802-5. PubMed ID: 21038645
    [No Abstract]   [Full Text] [Related]  

  • 28. [Toll-like receptors and their role in regulation of the inflammatory response in sepsis].
    Krawczyk-Michalak K; Glapiński A; Brzezińska-Błaszczyk E
    Anestezjol Intens Ter; 2008; 40(4):253-59. PubMed ID: 19517667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune stimulation in sepsis: to be or not to be?
    Napolitano LM
    Chest; 2005 Jun; 127(6):1882-5. PubMed ID: 15947295
    [No Abstract]   [Full Text] [Related]  

  • 30. Neutrophils in sepsis: battle of the bands.
    Kipnis E
    Crit Care Med; 2013 Mar; 41(3):925-6. PubMed ID: 23425832
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of granulocyte colony-stimulating factor on functional and histopathologic outcome after traumatic brain injury in mice.
    Sheibani N; Grabowski EF; Schoenfeld DA; Whalen MJ
    Crit Care Med; 2004 Nov; 32(11):2274-8. PubMed ID: 15640641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis.
    Zhang P; Bagby GJ; Stoltz DA; Summer WR; Nelson S
    Crit Care Med; 1998 Feb; 26(2):315-21. PubMed ID: 9468171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compartmentalization of the inflammatory response in sepsis and SIRS.
    Cavaillon JM; Annane D
    J Endotoxin Res; 2006; 12(3):151-70. PubMed ID: 16719987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innate immunity in sepsis pathogenesis and its modulation: new immunomodulatory targets revealed.
    Kumar V; Sharma A
    J Chemother; 2008 Dec; 20(6):672-83. PubMed ID: 19129063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the rationale for the use of granulocyte and granulocyte-macrophage colony-stimulating factors in the neonatal intensive care unit?
    La Gamma EF; De Castro MH
    Acta Paediatr Suppl; 2002; 91(438):109-16. PubMed ID: 12477273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic inflammatory response syndrome and compensatory anti-inflammatory response syndrome in sepsis.
    van der Poll T; Meijers JC
    J Innate Immun; 2010; 2(5):379-80. PubMed ID: 20606408
    [No Abstract]   [Full Text] [Related]  

  • 37. Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis.
    Bauhofer A; Lorenz W; Kohlert F; Torossian A
    Crit Care Med; 2006 Mar; 34(3):778-84. PubMed ID: 16521271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sepsis seesaw: tilting toward immunosuppression.
    Hotchkiss RS; Coopersmith CM; McDunn JE; Ferguson TA
    Nat Med; 2009 May; 15(5):496-7. PubMed ID: 19424209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathophysiology of sepsis and possible influence of statins].
    Fraunberger P; Drexel H; Walli AK
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2128-32. PubMed ID: 20960384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis.
    Eisen DP; Reid D; McBryde ES
    Crit Care Med; 2012 Jun; 40(6):1761-7. PubMed ID: 22610182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.